USNA USANA Health Sciences, Inc. Common Stock
O USANA Health Sciences, Inc. Common Stock Przegląd firmy z Wikipedii
USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.
Czytaj więcej
USANA Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.
History
In 1992, immunologist and microbiologist Myron Wentz moved his diagnostic testing company, Gull Laboratories, from Salt Lake City to West Valley City, Utah, and spun it into USANA Health Services, a multilevel marketing manufacturer of supplements. Beginning in 1993, Dallin A. Larsen served as USANA's vice president of sales (and later as a consultant to USANA's president and special advisor to the board of directors) before founding the MLM beverage company Monavie in 2005. USANA's products are not available through retail channels, and can only be obtained through one of its independent distributors (referred to as "associates") or by direct order through the company.
On 20 February 2007, Barry Minkow, founder of the Fraud Discovery Institute, distributed a 500-page report to officials at the U.S. Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the Internal Revenue Service (IRS) accusing USANA of operating an illegal pyramid scheme. The SEC conducted an investigation into USANA's business practices in March 2007 and found no evidence of wrongdoing, concluding its inquiry with no enforcement action recommended. Minkow acknowledged that he was shorting USANA's shares, hoping to profit from a drop in the stock price. In April 2007, a class action lawsuit was filed alleging that USANA's common stock had been artificially inflated. In August 2007, USANA was notified by the Securities and Exchange Commission (SEC) that its shares were subject to delisting from the NASDAQ due to its Form 10-Q, and was determined to be in compliance that October.
In January 2008, a shareholder suit was filed with allegations that USANA had misled investors about the sustainability of its growth and business model. The cases were dismissed, and the company was cleared by the U.S. Securities and Exchange Commission after an informal inquiry into the allegations, stating that it did "not intend to recommend any enforcement action by the Commission." Later that year, two Canadian USANA distributors were awarded $7 million in damages for their wrongful dismissal from the company. The firm had terminated their positions in 2003 because it believed the distributor had violated the companies' policies and procedures.
USANA filed suits against Minkow and his company claiming defamation and stock manipulation. USANA dropped the defamation suit and in March 2008 U.S. District Judge Tena Campbell threw out four of the five claims brought by USANA against Minkow ruling that USANA's claims violated California's anti-SLAPP law for suing Minkow for fair criticism and that USANA did not show a reasonable probability of winning on those claims. The remaining charge of stock manipulation was settled in July 2008, when USANA and Minkow reached an undisclosed settlement that included the removal of all USANA-related materials from the Fraud Discovery Institute website, a related Chinese website, and YouTube. Minkow also agreed to never trade in USANA's stock again.
In December 2010, USANA completed the application process to transfer its common stock listing from the NASDAQ National Market System, where it had traded since 1996, to the New York Stock Exchange. The transfer became official at the beginning of 2011. It received drug-establishment registration from the Food and Drug Administration to manufacture over-the-counter drugs later that year. In 2012, 91% of product sales were purchased by associates. The company acquired BabyCare Ltd., a China-based prenatal supplement company, in 2013 and announced plans to build a manufacturing facility in the country.
By 2018, USANA had reported record revenue due to growth in the Asia-Pacific region, though it recorded a 7% drop in net sales during its 2019 annual report. USANA has partnered with HealthCorps on health education for children and, in 2019, the USANA Foundation's Kids Eat program opened a facility to pack and distribute food for childhood hunger in the Utah area. It was also announced as the official nutritional partner of the Spartan Race endurance brand in the United States. Its sales for the first quarter of 2020 declined by 2.3 percent compared with 2019 numbers.
In February 2019, the Ministry of Commerce in China suspended operations of all multi-level marketing companies and participants to conduct a 100-day review of the country's health foods industry due to exaggerated advertising claims and questionable products in the unregulated sector. Chinese departments initiated "Hundred Days of Action" to clean up the health market, where 49 products from various companies were revoked, 54 food business licenses of various companies were revoked, 90 business licenses of various companies were revoked, and 465 counterfeit and fake dens were destroyed. 85 companies, including BabyCare Ltd., a USANA subsidiary, signed a declaration to self-discipline and regulate operations, with BabyCare speaking at an event hosted by the Chinese government.
Corporate affairs
Leadership
In 2007, USANA faced repeated controversy after members of its board of directors, medical advisory board and several of its executives made false statements regarding their qualifications, including education and licenses.
Founder Myron Wentz was the company's chief executive officer from 1992 until 2008, when his son, Dave Wentz, succeeded him after working in positions such as president, executive vice president, and senior vice president of strategic development. In 2015, USANA announced that the chief executive officer role would be divided between Wentz and Kevin Guest, with the former taking global operations and the latter, field development and sales. Guest was appointed the sole chief executive officer in November 2016.
Operations
USANA, a multilevel marketing company, sells its products primarily through non-employee distributors, known as sales "associates", as well as through the Internet. The firm's 2010 income disclosure statement defines "associates" as those who are actively building a business, acting as wholesale buyers, or are new distributors. The firm's 2009 SEC 10-K filing distinguishes between associates and preferred customers. Associates are independent distributors of USANA products and also purchase them for personal use. Preferred customers may purchase products at wholesale prices strictly for personal use and are not permitted to resell or distribute them. As of July 2011, the firm had 222,000 active Associates and 68,000 preferred customers. It manufactured 90% of its products at the Salt Lake City headquarters, which produced more than 22 million tablets each week.
Associates may be eligible to receive commissions based on their own product sales as well as through sales made by any new distributors they recruit. According to documentation from USANA corporate, 87 percent of associates fail to make enough from commissions to recover the cost of their qualifying purchases with 67 percent of all associates making no commission; the top 2.31 percent of associates earns 72.2 percent of the company's commissions. According to a 2011 article published by the Salt Lake City Tribune, the firm's FY09 income disclosure statement indicated that the average yearly income of the company's 165,710 associates, which includes those just starting, was $617, while the "top-of-the-pyramid distributors earn an average of $857,865 annually".
Sponsorships
USANA has been a paid sponsor of various athletic organizations. USANA offers an "Athlete Guarantee Program" to select sponsored athletes. The program permits selected participants to enter into an agreement with the company stipulating that, should an athlete enrolled in the program test positive for a banned substance (included in World Anti-Doping Agency regulations) as a result of taking USANA products, the company will compensate the athlete up to two times his or her current annual earnings up to $1 million USD.
In 2006, USANA signed a co-sponsorship agreement with the WTA Tour and extended it in 2011. The agreement provides athletes with nutritional supplements that are guaranteed to conform to the Tour's antidoping policy. As part of the agreement in 2011, USANA donated $1 to Children's Hunger Fund for every ace scored at a WTA tournament beginning at Wimbledon and continuing through the end of the season.
In 2003, USANA became the title sponsor of the USANA Amphitheatre, an outdoor amphitheatre based in West Valley City, Utah with a seating capacity of 20,000. In May 2012, United Concerts announced a continued naming rights partnership with USANA Health Sciences through March 2018.
In the lead-up to the 2020 Summer Olympics, USANA announced partnerships with USA Swimming and the USA Skateboarding National Team. It was the official multivitamin sponsor of USA Swimming and official nutritional supplement supplier of USA Skateboarding. The partnerships reportedly extended into multi-year agreements.
Products
USANA produces three product lines: USANA Nutritionals (Cellsentials, Optimizers, and Digestion/Detox nutritional supplements), USANA Diet & Energy (Reset meal replacement shakes, protein bars, and Rev3 energy drinks), and Sensé & Celavive personal care (skin care, skin treatment, and hair & body care products).
USANA Essentials were tested in 2011 by ConsumerLab.com in its Multivitamin and Multimineral Supplements Review of 38 leading multivitamin/multimineral products sold in the U.S. and Canada. The Essentials passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.
As of 2019, its products are marketed in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, the United Kingdom, the Caribbean, Puerto Rico, Philippines, France, China, Spain, Italy, Germany, Romania, Denmark, Colombia and Indonesia.
Reception
From 2004 to 2006, USANA was named on Forbes "200 Best Small Companies" list. In 2007, a Forbes article quoted industry experts and government officials who had raised questions about the cost of USANA's supplements and its business practices. Radio-Canada later aired an investigative report that examined the company's products, pricing and "misleading income claims" made to potential associates concerning revenue. It included hidden-camera footage of recruitment and other sessions, which found one group of associates appeared to violate the company's policies and distributor agreements. This contrasted with the Canadian legal requirements for multi-level marketing companies to provide clear, frequent and complete information about the revenue of the typical participant. In addition, the same group of associates were filmed making recommendations for using USANA products to treat illnesses including leukemia.
John Cloud, senior writer for Time Magazine, evaluated nutritional supplements in which he took a regimen of USANA pills, protein bars, powder drinks and psyllium fiber as recommended by the company's online evaluation. Cloud took a blood test before starting the products to measure levels of calcium, protein, sodium, cholesterol, glucose, and other substances, and was then tested again five months after starting the supplement regimen, which included 3,000 pills at a cost of $1,200. The follow-up test revealed a change in only two values; a 75% increase in vitamin D levels (attributed to the vitamin D3 supplement Cloud had been taking) and a 28 mg/dl increase in high-density lipoprotein, which could not be accounted for. Cloud also experienced a placebo response where that act of taking the supplements made him feel more vigorous despite no physiological reasons being present. This response also led to a 10-lb weight gain, as the belief that he was more vigorous led him to make poorer dietary decisions—a phenomenon referred to as the "licensing effect".
New Zealand government statistician for the Commerce Commission, Murray H. Smith, who served as an expert witness in every pyramid scheme case brought by the Commission preceding 10 years, opined in 2008 that very few USANA distributors are likely to become wealthy, and stated, "you can make a very strong argument that this could be a pyramid scheme." When asked by the National Business Review to review the firm's business structure and compensation plan, it was Smith's opinion, from a statistical not legal standpoint, that the firm demonstrated a number of characteristics commonly occurring in pyramid schemes including that most members recoup less than what they pay to participate; that those at the top of the structure are more likely to make more than those on the bottom of the structure; and that as the company grows it will become harder to recruit others. Smith also noted the company's significant turnover in distributors making it necessary to continually recruit.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
USNA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
USNA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
USNA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 0 0,0%
- Kup 0 0,0%
- Trzymaj 3 50,0%
- Sprzedaj 1 16,7%
- Mocna sprzedaż 2 33,3%
12-miesięczny cel cenowy
1 analityków · 2026-08-14Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.07 | $0.44 | -0.51% |
| 31 marca 2026 | $0.61 | $0.45 | 0.16% |
| 31 grudnia 2025 | $0.60 | $0.42 | 0.18% |
| 30 września 2025 | $-0.15 | $0.48 | -0.63% |
| 30 czerwca 2025 | $0.74 | $0.55 | 0.19% |
| 31 marca 2025 | $0.73 | $0.71 | 0.02% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| USNA | $355M | 33.5 | 8.3% | 1.2% | 2.0% | 78.3% |
| BRBR | $4.39B | 21.6 | 16.1% | 9.3% | -72.0% | 33.3% |
| HNST | $291M | -18.4 | -1.9% | -4.2% | -8.8% | 33.3% |
| NATR | $378M | 20.4 | 5.7% | 4.1% | 12.0% | 72.4% |
| NAGE | $507M | 31.8 | 29.9% | 13.4% | 24.7% | 64.3% |
| NUS | — | 3.0 | -14.3% | 10.8% | 22.0% | 69.5% |
| MED | $117M | -6.3 | -36.0% | -4.8% | -9.0% | 71.3% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $925M | $855M | $921M | $999M | $1.19B | $1.13B | $1.06B | $1.19B | $1.05B | $1.01B | $918M | $790M | |
| Cost of Revenue | $201M | $161M | $177M | $194M | $218M | $209M | $188M | $201M | $179M | $180M | $160M | $141M | |
| Gross Profit | $724M | $693M | $744M | $805M | $969M | $926M | $873M | $989M | $868M | $826M | $759M | $650M | |
| R&D Expense | $11M | $12M | $11M | $12M | $11M | $11M | $10M | $10M | $9M | $9M | $6M | $5M | |
| SG&A Expense | $337M | $263M | $257M | $262M | $279M | $261M | $268M | $275M | $265M | $234M | $209M | $185M | |
| Operating Expenses | $687M | $627M | $651M | $697M | $798M | $749M | $727M | $800M | $735M | $687M | $617M | $534M | |
| Operating Income | $37M | $66M | $93M | $108M | $170M | $176M | $146M | $188M | $133M | $139M | $142M | $116M | |
| Interest Expense | · | · | $262.0K | $192.0K | $57.0K | $507.0K | $66.0K | $36.0K | $46.0K | $444.0K | $15.0K | $129.0K | |
| Interest Income | $2M | $11M | $10M | $4M | $3M | $3M | $5M | $4M | $2M | $1M | $1M | $500.0K | |
| Other Non-op | $3M | $-1M | $7.0K | $-3M | $-2M | $-571.0K | $-335.0K | $-1M | $-3.0K | $-1M | $-174.0K | $-820.0K | |
| Pretax Income | $42M | $76M | $102M | $109M | $171M | $178M | $150M | $192M | $135M | $139M | $143M | $116M | |
| Income Tax | $30M | $34M | $39M | $39M | $54M | $53M | $50M | $65M | $72M | $39M | $48M | $39M | |
| Net Income | $11M | $42M | $64M | $69M | $117M | $125M | $101M | $126M | $63M | $100M | $95M | $77M | |
| EPS (Basic) | $0.58 | $2.20 | $3.31 | $3.60 | $5.78 | $5.89 | $4.44 | $5.24 | $2.57 | $4.14 | $3.72 | $2.90 | |
| EPS (Diluted) | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 | $5.86 | $4.41 | $5.12 | $2.53 | $3.99 | $3.59 | $2.80 | |
| Shares (Basic) | 18,535,000 | 19,103,000 | 19,250,000 | 19,254,000 | 20,146,000 | 21,156,000 | 22,644,000 | 24,105,000 | 24,349,000 | 24,185,000 | 25,460,000 | 26,443,000 | |
| Shares (Diluted) | 18,574,000 | 19,162,000 | 19,345,000 | 19,310,000 | 20,343,000 | 21,256,000 | 22,818,000 | 24,642,000 | 24,708,000 | 25,047,000 | 26,355,000 | 27,377,000 | |
| EBITDA | $70M | $81M | $106M | $121M | $183M | $190M | $161M | $205M | $149M | $152M | $152M | $125M |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $158M | $182M | $330M | $288M | $240M | $312M | $235M | $214M | $247M | $176M | $143M | $111M | |
| Receivables | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $103M | $70M | $61M | $67M | $98M | $90M | $69M | $82M | $63M | $65M | $66M | $45M | |
| Prepaid Expense | $23M | $28M | $26M | $29M | $27M | $23M | $26M | $33M | $30M | $37M | $35M | $35M | |
| Other Current Assets | $5M | $5M | $6M | $7M | $4M | $5M | $5M | $7M | $5M | $6M | $5M | $6M | |
| Current Assets | $288M | $279M | $418M | $384M | $365M | $425M | $329M | $392M | $340M | $278M | $244M | $191M | |
| PP&E (Net) | $94M | $95M | $100M | $98M | $102M | $100M | $95M | $92M | $103M | $101M | $88M | $71M | |
| PP&E (Gross) | · | · | $212M | $210M | $211M | $199M | $181M | $178M | $177M | $164M | $120M | $114M | |
| Accum. Depreciation | $135M | $130M | $129M | $125M | $122M | $116M | $105M | $96M | $86M | $76M | $71M | $64M | |
| Goodwill | $138M | $144M | $17M | $17M | $18M | $17M | $17M | $17M | $17M | $17M | $17M | $18M | |
| Intangibles | $133M | $152M | $30M | $32M | $30M | $31M | $30M | $32M | $35M | $34M | $38M | $41M | |
| Other Non-current Assets | $62M | $59M | $55M | $55M | $58M | $62M | $43M | $18M | $21M | $22M | $25M | $24M | |
| Total Assets | $743M | $748M | $633M | $597M | $578M | $641M | $517M | $554M | $519M | $471M | $423M | $351M | |
| Accounts Payable | $17M | $12M | $10M | $11M | $14M | $18M | $13M | $10M | $12M | $9M | $10M | $8M | |
| Accrued Liabilities | $10M | $14M | $10M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $129M | $140M | $119M | $144M | $161M | $168M | $136M | $149M | $141M | $138M | $131M | $109M | |
| Capital Leases | $12M | $10M | $5M | $8M | $10M | · | $17M | · | · | · | · | · | |
| Deferred Tax | $5M | $4M | $5M | $4M | $7M | $12M | $10M | $13M | $14M | $5M | $10M | $11M | |
| Other Non-current Liabilities | $23M | $18M | $12M | $14M | $14M | $19M | $19M | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $157M | $162M | $136M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $18.0K | $19.0K | $19.0K | $19.0K | $19.0K | $21.0K | $22.0K | $24.0K | $24.0K | $24.0K | $25.0K | $13.0K | |
| Retained Earnings | $466M | $479M | $445M | $392M | $345M | $383M | $306M | $330M | $288M | $265M | $215M | $166M | |
| AOCI | $-16M | $-23M | $-14M | $-13M | $458.0K | $-4M | $-14M | $-10M | $-1M | $-12M | $-4M | $2M | |
| Stockholders' Equity | $533M | $532M | $497M | $434M | $395M | $442M | $352M | $391M | $363M | $325M | $281M | $230M | |
| Liabilities + Equity | $743M | $748M | $633M | $597M | $578M | $641M | $517M | $554M | $519M | $471M | $423M | $351M | |
| Shares Outstanding | 18,281,000 | 19,064,000 | 19,130,000 | 19,206,000 | 19,393,000 | 21,038,000 | 21,655,000 | 23,567,000 | 24,024,000 | 24,485,000 | 24,976,000 | 25,266,000 |
Przepływy pieniężne 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $33M | $15M | $13M | $13M | $13M | $14M | $15M | $17M | $16M | $13M | $10M | $9M | |
| Stock-based Comp | $14M | $15M | $15M | $13M | $14M | $14M | $16M | $15M | $15M | $17M | $11M | $10M | |
| Deferred Tax | $-7M | $-7M | $-3M | $-7M | $-3M | $-2M | $-4M | $607.0K | $19M | $-4M | $-3M | $-1M | |
| Amort. of Intangibles | $19M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $1M | $2M | $900.0K | $431.0K | |
| Restructuring | $6M | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-28M | $-3M | $-18M | $15M | $-20M | $10M | $-442.0K | $-7M | $10M | $11M | $-2M | $11M | |
| Operating Cash Flow | $22M | $61M | $71M | $104M | $121M | $160M | $127M | $152M | $124M | $137M | $111M | $105M | |
| CapEx | $14M | $10M | $14M | $10M | $13M | $15M | $17M | $11M | $13M | $33M | $24M | $20M | |
| Investing Cash Flow | $-10M | $-213M | $-12M | $-12M | $-14M | $-34M | $47M | $-69M | $-13M | $-32M | $-25M | $-16M | |
| Stock Repurchased | $28M | $9M | $12M | $25M | $178M | $57M | $150M | $105M | $50M | $65M | $61M | $139M | |
| Net Stock Activity | $-28M | $-9M | $-12M | $-25M | $-178M | $-57M | $-150M | $-105M | $-50M | $-65M | $-61M | $-139M | |
| Financing Cash Flow | $-41M | $10M | $-14M | $-30M | $-181M | $-59M | $-152M | $-105M | $-50M | $-65M | $-49M | $-113M | |
| Net Change in Cash | $-23M | $-149M | $42M | $48M | $-72M | $78M | $20M | $-33M | $72M | $32M | $32M | $-26M | |
| Taxes Paid | $37M | $40M | $42M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $9M | $51M | $56M | $94M | $108M | $145M | $110M | $141M | $111M | $104M | $88M | $85M | |
| Levered FCF | · | · | $56M | $93M | $108M | $145M | $110M | $141M | $111M | $104M | $88M | $85M |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.3% | 81.1% | 80.8% | 80.6% | 81.6% | 81.6% | 82.3% | 83.1% | 82.9% | 82.1% | 82.6% | 82.2% | |
| Operating Margin | 4.0% | 7.8% | 10.1% | 10.8% | 14.3% | 15.6% | 13.8% | 15.8% | 12.7% | 13.8% | 15.4% | 14.7% | |
| Net Margin | 1.2% | 4.9% | 6.9% | 6.9% | 9.8% | 11.0% | 9.5% | 10.6% | 6.0% | 9.9% | 10.3% | 9.7% | |
| Pretax Margin | 4.5% | 8.9% | 11.1% | 10.9% | 14.4% | 15.7% | 14.2% | 16.1% | 12.9% | 13.8% | 15.5% | 14.6% | |
| EBITDA Margin | 7.6% | 9.5% | 11.5% | 12.1% | 15.4% | 16.8% | 15.2% | 17.2% | 14.2% | 15.1% | 16.5% | 15.8% | |
| ROA | 1.4% | 6.1% | 10.4% | 11.8% | 19.1% | 21.5% | 18.8% | 23.5% | 12.6% | 22.4% | 24.5% | 21.3% | |
| ROE | 2.0% | 7.9% | 13.2% | 16.4% | 29.3% | 30.0% | 30.2% | 30.5% | 17.2% | 33.0% | 37.0% | 31.2% | |
| ROIC | 1.9% | 6.9% | 11.7% | 15.8% | 29.4% | 28.0% | 27.8% | 31.7% | 16.9% | 30.8% | 33.5% | 33.4% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 2.0 | 3.5 | 2.7 | 2.3 | 2.5 | 2.4 | 2.6 | 2.4 | 2.0 | 1.9 | 1.8 | |
| Quick Ratio | 1.2 | 1.3 | 2.8 | 2.0 | 1.5 | 1.9 | 1.7 | 1.4 | 1.8 | 1.3 | 1.1 | 1.0 | |
| Interest Coverage | · | · | 355.2 | 560.5 | 2985.8 | 348.1 | 2215.0 | 5232.0 | 2880.5 | 312.2 | 9444.1 | 900.0 |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.5 | 1.7 | 1.9 | 2.0 | 2.0 | 2.2 | 2.1 | 2.3 | 2.4 | 2.2 | |
| Inventory Turnover | 2.3 | 2.5 | 2.7 | 2.3 | 2.3 | 2.2 | 2.5 | 2.8 | 2.8 | 2.8 | 2.9 | 3.0 |
Stopy Wzrostu 9
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.3% | -7.2% | -7.8% | -15.8% | 4.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.5% | -10.4% | -6.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -4.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -73.5% | -33.6% | -8.1% | -37.4% | -2.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -45.5% | -27.4% | -17.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -37.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -74.4% | -34.1% | -8.0% | -40.5% | -6.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -46.3% | -28.8% | -20.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -38.7% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $925M | $855M | $921M | $999M | $1.19B | $1.13B | $1.06B | $1.19B | $1.05B | $1.01B | $918M | $790M | |
| Net Income TTM | $11M | $42M | $64M | $69M | $117M | $125M | $101M | $126M | $63M | $100M | $95M | $77M | |
| Market Cap | $355M | $680M | $1.03B | $1.02B | $1.96B | $1.62B | $1.73B | $2.71B | $1.78B | $1.50B | $798M | $646M | |
| P/E | 33.5 | 16.3 | 16.2 | 14.8 | 17.7 | 13.2 | 18.1 | 22.5 | 29.3 | 15.3 | 17.8 | 18.3 | |
| P/S | 0.4 | 0.8 | 1.1 | 1.0 | 1.7 | 1.4 | 1.6 | 2.3 | 1.7 | 1.5 | 0.9 | 0.8 | |
| P/B | 0.7 | 1.3 | 2.1 | 2.4 | 5.0 | 3.7 | 4.9 | 6.9 | 4.9 | 4.6 | 2.8 | 2.8 | |
| P / Tangible Book | 1.4 | 2.9 | 2.3 | 2.7 | 5.7 | 4.1 | · | · | · | · | · | · | |
| P / Cash Flow | 15.9 | 11.2 | 14.5 | 9.8 | 16.2 | 10.1 | 13.7 | 17.8 | 14.4 | 10.9 | 7.2 | 6.1 | |
| P / FCF | 41.7 | 13.4 | 18.3 | 10.9 | 18.1 | 11.2 | 15.7 | 19.3 | 16.1 | 14.4 | 9.1 | 7.6 | |
| Earnings Yield | 3.0% | 6.1% | 6.2% | 6.8% | 5.7% | 7.6% | 5.5% | 4.5% | 3.4% | 6.5% | 5.6% | 5.5% |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $223M | $250M | $240M | $214M | $236M | $250M | $214M | $200M | $213M | $228M | $221M | $213M | $248M | $153M | |
| Cost of Revenue | $48M | $59M | $59M | $49M | $50M | $52M | $39M | $39M | $40M | $43M | $42M | $43M | $49M | $35M | |
| Gross Profit | $175M | $191M | $181M | $165M | $186M | $197M | $175M | $161M | $173M | $185M | $179M | $171M | $200M | $118M | |
| SG&A Expense | $82M | $88M | $103M | $86M | $82M | $91M | $73M | $61M | $64M | $64M | $59M | $63M | $67M | $55M | |
| Operating Expenses | $195M | $177M | $191M | $164M | $169M | $181M | $167M | $145M | $155M | $160M | $155M | $153M | $173M | $117M | |
| Operating Income | $-20M | $14M | $-11M | $1M | $17M | $16M | $8M | $16M | $18M | $25M | $24M | $18M | $27M | $984.0K | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $52.0K | · | $43.0K | $31.0K | · | |
| Interest Income | $595.0K | $437.0K | $-2M | $578.0K | $619.0K | $723.0K | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-op | $501.0K | $1M | $113.0K | $41.0K | $2M | $756.0K | $-390.0K | $-86.0K | $-349.0K | $-186.0K | $-368.0K | $234.0K | $-88.0K | $-852.0K | |
| Pretax Income | $-19M | $15M | $-13M | $2M | $19M | $17M | $10M | $19M | $20M | $27M | $27M | $21M | $29M | $2M | |
| Income Tax | $9M | $9M | $6M | $8M | $8M | $7M | $6M | $8M | $10M | $11M | $10M | $9M | $10M | $5M | |
| Net Income | $-21M | $8M | $-19M | $-7M | $10M | $9M | $4M | $11M | $10M | $17M | $17M | $11M | $18M | $-3M | |
| EPS (Basic) | $-1.16 | $0.41 | $-0.99 | $-0.36 | $0.52 | $0.49 | $0.23 | $0.56 | $0.55 | $0.86 | $0.87 | $0.59 | $0.95 | $-0.03 | |
| EPS (Diluted) | $-1.16 | $0.41 | $-0.99 | $-0.36 | $0.52 | $0.49 | $0.23 | $0.56 | $0.54 | $0.86 | $0.87 | $0.59 | $0.95 | $-0.01 | |
| Shares (Basic) | 18,486,000 | 18,398,000 | -38,105,000 | 18,293,000 | 18,513,000 | 19,049,000 | -38,222,000 | 19,078,000 | 19,073,000 | 19,174,000 | -33,000 | 19,245,000 | 19,283,000 | -40,204,000 | |
| Shares (Diluted) | 18,486,000 | 18,411,000 | -38,130,000 | 18,293,000 | 18,536,000 | 19,085,000 | -38,382,000 | 19,083,000 | 19,159,000 | 19,302,000 | -31,000 | 19,372,000 | 19,328,000 | -40,511,000 | |
| EBITDA | $-12M | $22M | · | $9M | $24M | $24M | · | $16M | $18M | $28M | · | $18M | $30M | · |
Bilans 25
| Wskaźnik | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $169M | $163M | $158M | $145M | $151M | $180M | $182M | $365M | $332M | $328M | $330M | $307M | $295M | $288M | |
| Receivables | $3M | $10M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $86M | $96M | $103M | $91M | $83M | $74M | $70M | $64M | $62M | $61M | · | $60M | $64M | · | |
| Prepaid Expense | $23M | $25M | $27M | $28M | $27M | $28M | $28M | $22M | $25M | $32M | · | $23M | $36M | · | |
| Other Current Assets | · | · | $5M | · | · | · | $5M | · | · | · | · | · | · | · | |
| Current Assets | $281M | $294M | $288M | $264M | $262M | $281M | $279M | $451M | $419M | $421M | · | $390M | $396M | · | |
| PP&E (Net) | $94M | $95M | $94M | $96M | $97M | $94M | $95M | $98M | $98M | $98M | · | $95M | $97M | · | |
| Accum. Depreciation | · | · | $135M | · | · | · | $130M | · | · | · | · | · | · | · | |
| Goodwill | $109M | $138M | $138M | $144M | $144M | $144M | $144M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $125M | $129M | $133M | $138M | $143M | $147M | $152M | $29M | $29M | $29M | · | $29M | $32M | · | |
| Other Non-current Assets | $65M | $58M | $62M | $60M | $63M | $61M | $59M | $59M | $51M | $53M | · | $54M | $56M | · | |
| Total Assets | $703M | $739M | $743M | $727M | $735M | $747M | $748M | $671M | $631M | $629M | · | $601M | $606M | · | |
| Accounts Payable | $15M | $16M | $17M | $16M | $18M | $14M | $12M | $7M | $7M | $8M | · | $9M | $11M | · | |
| Accrued Liabilities | · | · | $10M | · | · | · | $14M | · | · | · | · | · | · | · | |
| Current Liabilities | $106M | $117M | $129M | $119M | $122M | $137M | $140M | $115M | $104M | $113M | · | $113M | $130M | · | |
| Capital Leases | · | · | $12M | · | · | · | $10M | · | · | · | · | · | · | · | |
| Deferred Tax | $5M | $5M | $5M | $4M | $5M | $5M | $4M | $5M | $5M | $5M | · | $5M | $6M | · | |
| Other Non-current Liabilities | $22M | $22M | $23M | $22M | $23M | $21M | $18M | $19M | $11M | $12M | · | $13M | $14M | · | |
| Total Liabilities | $132M | $144M | $157M | $145M | $149M | $163M | $162M | · | · | · | · | · | · | · | |
| Common Stock | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | · | $19.0K | $19.0K | · | |
| Retained Earnings | $452M | $473M | $466M | $467M | $474M | $478M | $479M | $474M | $464M | $453M | · | $428M | $410M | · | |
| AOCI | $-14M | $-14M | $-16M | $-19M | $-19M | $-23M | $-23M | $-14M | $-21M | $-19M | · | $-20M | $-11M | · | |
| Stockholders' Equity | $526M | $544M | $533M | $528M | $531M | $530M | $532M | $533M | $512M | $500M | $497M | $470M | $455M | $434M | |
| Liabilities + Equity | $703M | $739M | $743M | $727M | $735M | $747M | $748M | $671M | $631M | $629M | · | $601M | $606M | · | |
| Shares Outstanding | 18,463,000 | 18,457,000 | 18,281,000 | 18,272,000 | 18,262,000 | 18,786,000 | 19,064,000 | 19,056,000 | 19,051,000 | 19,047,000 | 19,130,000 | 19,122,000 | 19,294,000 | 19,206,000 |
Przepływy pieniężne 12
| Wskaźnik | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $13M | $8M | $8M | $8M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $3M | $3M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | · | · | · | · | · | $-5M | · | · | · | $-6M | · | · | $-12M | · | |
| Operating Cash Flow | $23M | $10M | $-33M | $-2M | $12M | $15M | $6M | $28M | $8M | $18M | $26M | $22M | $13M | $40M | |
| CapEx | $3M | $3M | $6M | $3M | $5M | $3M | $2M | $441.0K | $3M | $3M | $7M | $1M | $2M | $3M | |
| Investing Cash Flow | $-4M | $-3M | $-2M | $-3M | $-4M | $-4M | $-205M | $85.0K | $-2M | $-4M | $-7M | $-1M | $-3M | $-3M | |
| Stock Repurchased | $0 | $0 | $18M | $0 | $15M | $12M | $0 | $-18M | $0 | $9M | $0 | $12M | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-12M | · | · | · | $-9M | · | · | $0 | · | |
| Financing Cash Flow | $-14M | $-4M | $-27M | $-979.0K | $-39M | $-14M | $23M | $40M | $-1M | $-12M | $658.0K | $-12M | $-3M | $-150.0K | |
| Net Change in Cash | $6M | $4M | $-58M | $-6M | $-28M | $-2M | $-183M | $65M | $4M | $-2M | $23M | $7M | $7M | $41M | |
| Free Cash Flow | · | $7M | · | · | · | $13M | · | · | · | $14M | · | · | $11M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $14M | · | · | $11M | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.3% | 76.2% | · | 77.1% | 78.7% | 79.0% | · | 80.4% | 81.0% | 81.1% | · | 80.1% | 80.5% | · | |
| Operating Margin | -9.0% | 5.5% | · | 0.57% | 7.1% | 6.3% | · | 7.8% | 8.4% | 10.8% | · | 8.2% | 10.8% | · | |
| Net Margin | -9.6% | 3.0% | · | -3.0% | 4.1% | 3.8% | · | 5.3% | 4.9% | 7.3% | · | 5.3% | 7.4% | · | |
| Pretax Margin | -8.5% | 6.2% | · | 0.84% | 8.0% | 6.7% | · | 9.3% | 9.5% | 11.9% | · | 9.6% | 11.5% | · | |
| EBITDA Margin | -5.5% | 8.8% | · | 4.3% | 10.4% | 9.6% | · | 7.8% | 8.4% | 12.2% | · | 8.2% | 12.1% | · | |
| ROA | -3.0% | 1.0% | · | -0.93% | 1.4% | 1.4% | · | 1.7% | 1.7% | 2.7% | · | 2.0% | · | · | |
| ROE | -4.0% | 1.4% | · | -1.2% | 1.8% | 1.8% | · | 2.1% | 2.1% | 3.5% | · | 2.6% | · | · | |
| ROIC | -5.6% | 1.1% | · | -0.86% | 1.8% | 1.6% | · | 1.7% | 1.8% | 3.0% | · | 2.1% | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 2.5 | · | 2.2 | 2.2 | 2.0 | · | 3.9 | 4.0 | 3.7 | · | 3.5 | · | · | |
| Quick Ratio | 1.6 | · | · | 1.2 | 1.2 | 1.3 | · | 3.2 | 3.2 | 2.9 | · | 2.7 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 474.5 | · | 409.5 | 866.0 | · |
Efektywność 3
| Wskaźnik | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | · | · | |
| Inventory Turnover | 0.6 | 0.7 | · | 0.6 | 0.7 | 0.8 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | · | · | |
| Receivables Turnover | 133.8 | 51.8 | · | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $923M | $949M | · | $899M | $898M | $890M | · | $854M | $892M | $928M | · | $933M | $1.02B | · | |
| Net Income TTM | $-11M | $20M | · | $23M | $40M | $47M | · | $49M | $56M | $64M | · | $62M | $75M | · | |
| Market Cap | $397M | $312M | · | $521M | $568M | $522M | · | $723M | $862M | $924M | · | $1.12B | · | · | |
| P/E | -36.5 | 15.9 | · | 23.6 | 14.8 | 11.3 | · | 14.9 | 15.7 | 14.7 | · | 18.3 | 16.2 | · | |
| P/S | 0.4 | 0.3 | · | 0.6 | 0.6 | 0.6 | · | 0.8 | 1.0 | 1.0 | · | 1.2 | · | · | |
| P/B | 0.8 | 0.6 | · | 1.0 | 1.1 | 1.0 | · | 1.4 | 1.7 | 1.8 | · | 2.4 | · | · | |
| P / Tangible Book | 1.4 | 1.1 | · | 2.1 | 2.3 | 2.2 | · | 1.5 | 1.8 | 2.0 | · | 2.6 | · | · | |
| P / Cash Flow | · | 32.0 | · | · | · | 33.7 | · | · | · | 52.2 | · | · | · | · | |
| P / FCF | · | 43.8 | · | · | · | 41.2 | · | · | · | 63.8 | · | · | · | · | |
| Earnings Yield | -2.7% | 6.3% | · | 4.2% | 6.8% | 8.8% | · | 6.7% | 6.4% | 6.8% | · | 5.5% | 6.2% | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | |
|---|---|---|---|---|---|
| Przychody | $925M | $855M | $921M | $999M | $1.19B |
| Marża Brutto % | 78.3% | 81.1% | 80.8% | 80.6% | 81.6% |
| Marża Operacyjna % | 4.0% | 7.8% | 10.1% | 10.8% | 14.3% |
| Zysk netto | $11M | $42M | $64M | $69M | $117M |
| Rozwodniony EPS | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 |
Bilans
| 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 2.2 | 2.0 | 3.5 | 2.7 | 2.3 |
| Wskaźnik Szybkości | 1.2 | 1.3 | 2.8 | 2.0 | 1.5 |
Przepływy pieniężne
| 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $9M | $51M | $56M | $94M | $108M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 152 emitenci · $176.6M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 30 (+4 vs poprzedni kw.) | 16 (+6 vs poprzedni kw.) | 48 (+5 vs poprzedni kw.) | 34 (-7 vs poprzedni kw.) | +1.1M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| PZENA INVESTMENT MANAGEMENT LLC | $25 739 282 | 1 205 587 | 14,58% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $20 464 402 | 958 520 | 11,59% | Akcje |
| Nantahala Capital Management, LLC | $17 295 080 | 810 074 | 9,80% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $16 958 134 | 794 292 | 9,61% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $10 405 350 | 487 370 | 5,89% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7 758 099 | 363 377 | 4,39% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $5 811 641 | 272 208 | 3,29% | Akcje |
| STATE STREET CORP | $5 577 474 | 261 240 | 3,16% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $5 175 448 | 242 342 | 2,93% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $3 999 880 | 187 348 | 2,27% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3 855 105 | 180 567 | 2,18% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $3 533 724 | 165 514 | 2,00% | Akcje |
| D. E. Shaw & Co., Inc. | $3 348 427 | 156 835 | 1,90% | Akcje |
| Allianz Asset Management GmbH | $3 040 219 | 142 399 | 1,72% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $2 949 567 | 138 153 | 1,67% | Akcje |
| ALGERT GLOBAL LLC | $2 813 033 | 131 758 | 1,59% | Akcje |
| UBS Group AG | $2 474 166 | 115 886 | 1,40% | Akcje |
| BlackRock, Inc. | $2 353 005 | 110 211 | 1,33% | Akcje |
| LAZARD ASSET MANAGEMENT LLC | $2 077 590 | 97 311 | 1,18% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $1 549 540 | 72 578 | 0,88% | Akcje |
| Vanguard Global Advisers, LLC | $1 514 569 | 70 940 | 0,86% | Akcje |
| Empowered Funds, LLC | $1 499 902 | 70 253 | 0,85% | Akcje |
| AMERIPRISE FINANCIAL INC | $1 443 624 | 67 617 | 0,82% | Akcje |
| TWO SIGMA ADVISERS, LP | $1 289 691 | 65 700 | 0,73% | Akcje |
| GOLDMAN SACHS GROUP INC | $1 121 921 | 52 549 | 0,64% | Akcje |
| Quantinno Capital Management LP | $1 072 261 | 50 223 | 0,61% | Akcje |
| BANK OF AMERICA CORP /DE/ | $967 539 | 45 318 | 0,55% | Akcje |
| ROYCE & ASSOCIATES LP | $884 039 | 41 407 | 0,50% | Akcje |
| DEUTSCHE BANK AG\ | $821 975 | 38 500 | 0,47% | Akcje |
| Assenagon Asset Management S.A. | $815 848 | 38 213 | 0,46% | Akcje |
| BARCLAYS PLC | $769 220 | 36 029 | 0,44% | Akcje |
| STRS OHIO | $723 765 | 33 900 | 0,41% | Akcje |
| Skopos Labs, Inc. | $673 696 | 38 563 | 0,38% | Akcje |
| HSBC HOLDINGS PLC | $672 758 | 31 960 | 0,38% | Akcje |
| Bank of New York Mellon Corp | $668 447 | 31 309 | 0,38% | Akcje |
| XTX Topco Ltd | $625 320 | 29 289 | 0,35% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $570 728 | 26 732 | 0,32% | Akcje |
| CITADEL ADVISORS LLC | $569 639 | 26 681 | 0,32% | Akcje |
| Verdad Advisers, LP | $556 552 | 26 068 | 0,32% | Akcje |
| Sanctuary Advisors, LLC | $497 113 | 23 284 | 0,28% | Akcje |
| Man Group plc | $489 854 | 22 944 | 0,28% | Akcje |
| State of Tennessee, Department of Treasury | $461 160 | 21 600 | 0,26% | Akcje |
| Point72 Asset Management, L.P. | $397 238 | 18 606 | 0,22% | Akcje |
| Unison Advisors LLC | $384 300 | 18 000 | 0,22% | Akcje |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $384 215 | 17 996 | 0,22% | Akcje |
| Numerai GP LLC | $382 080 | 17 896 | 0,22% | Akcje |
| KLP KAPITALFORVALTNING AS | $375 760 | 17 600 | 0,21% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $366 836 | 17 182 | 0,21% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $357 611 | 20 470 | 0,20% | Akcje |
| CITADEL ADVISORS LLC | $356 545 | 16 700 | 0,20% | Opcja sprzedaży |
| Park Capital Management, LLC / WI | $345 144 | 16 166 | 0,20% | Akcje |
| Engineers Gate Manager LP | $337 672 | 15 816 | 0,19% | Akcje |
| SEGALL BRYANT & HAMILL, LLC | $318 414 | 14 914 | 0,18% | Akcje |
| RHUMBLINE ADVISERS | $309 778 | 14 510 | 0,18% | Akcje |
| Vanguard Personalized Indexing Management, LLC | $309 724 | 14 507 | 0,18% | Akcje |
| FIRST TRUST ADVISORS LP | $308 998 | 14 473 | 0,18% | Akcje |
| Toroso Investments, LLC | $304 756 | 15 525 | 0,17% | Akcje |
| EXCHANGE TRADED CONCEPTS, LLC | $300 992 | 14 098 | 0,17% | Akcje |
| IEQ CAPITAL, LLC | $300 245 | 14 063 | 0,17% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $298 366 | 13 975 | 0,17% | Akcje |
| Focus Partners Wealth | $292 794 | 13 714 | 0,17% | Akcje |
| CITADEL ADVISORS LLC | $273 280 | 12 800 | 0,15% | Opcja kupna |
| BNP PARIBAS FINANCIAL MARKETS | $263 160 | 12 326 | 0,15% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $243 881 | 11 423 | 0,14% | Akcje |
| State of Wyoming | $242 237 | 11 346 | 0,14% | Akcje |
| ANCHYRA PARTNERS LLC | $230 238 | 10 784 | 0,13% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $229 982 | 10 772 | 0,13% | Akcje |
| OCCUDO QUANTITATIVE STRATEGIES LP | $226 652 | 10 616 | 0,13% | Akcje |
| Mariner, LLC | $219 915 | 10 302 | 0,12% | Akcje |
| DGS Capital Management, LLC | $207 876 | 11 899 | 0,12% | Akcje |
| Cerity Partners LLC | $141 913 | 6 647 | 0,08% | Akcje |
| Magnetar Financial LLC | $138 540 | 6 489 | 0,08% | Akcje |
| MetLife Investment Management, LLC | $124 236 | 5 819 | 0,07% | Akcje |
| Russell Investments Group, Ltd. | $123 637 | 5 791 | 0,07% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $109 931 | 5 149 | 0,06% | Akcje |
| Creative Planning | $107 156 | 5 019 | 0,06% | Akcje |
| FMR LLC | $105 661 | 4 949 | 0,06% | Akcje |
| SIGNATUREFD, LLC | $101 391 | 4 749 | 0,06% | Akcje |
| CWM, LLC | $97 413 | 5 576 | 0,06% | Akcje |
| VANGUARD GROUP INC | $96 226 | 4 902 | 0,05% | Akcje |
| Invesco Ltd. | $95 072 | 4 453 | 0,05% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $81 045 | 3 796 | 0,05% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $73 935 | 3 463 | 0,04% | Akcje |
| Parallel Advisors, LLC | $70 818 | 3 317 | 0,04% | Akcje |
| Farther Finance Advisors, LLC | $41 873 | 1 964 | 0,02% | Akcje |
| Arax Advisory Partners | $40 588 | 1 901 | 0,02% | Akcje |
| NATIONAL BANK OF CANADA /FI/ | $40 499 | 1 896 | 0,02% | Akcje |
| AlphaQuest LLC | $38 259 | 1 949 | 0,02% | Akcje |
| NORTHERN TRUST CORP | $37 533 | 1 758 | 0,02% | Akcje |
| OSAIC HOLDINGS, INC. | $34 383 | 1 611 | 0,02% | Akcje |
| LOM Asset Management Ltd | $34 160 | 1 600 | 0,02% | Akcje |
| Versant Capital Management, Inc | $33 904 | 1 588 | 0,02% | Akcje |
| MORGAN STANLEY | $31 363 | 1 469 | 0,02% | Akcje |
| Ameritas Investment Partners, Inc. | $23 933 | 1 121 | 0,01% | Akcje |
| Tower Research Capital LLC (TRC) | $22 909 | 1 073 | 0,01% | Akcje |
| Legal & General Group Plc | $20 966 | 982 | 0,01% | Akcje |
| Integrated Wealth Concepts LLC | $18 833 | 882 | 0,01% | Akcje |
| CITIGROUP INC | $17 635 | 826 | 0,01% | Akcje |
| Global Retirement Partners, LLC | $14 433 | 676 | 0,01% | Akcje |
| Allworth Financial LP | $14 027 | 657 | 0,01% | Akcje |
Insiderzy spółki 38 insiderów · 20 dyrektorzy generalni · 13 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jim Brown | CEO & PRESIDENT | 24 lipca 2025 M | 16 934 | 0 | 0 | $0 |
| Doug G Iiekking | CHIEF FINANCIAL OFFICER | 27 maja 2026 S | 0 | 0 | 1 | $-100 500 |
| Jeffrey Yates | Chief Financial Officer | 28 października 2010 M | 0 | 0 | 0 | $0 |
| Deborah Woo | President of Asia | 8 września 2016 M | 1 479 | 0 | 0 | $0 |
| Fred W Cooper | President and COO | 28 października 2010 M | 0 | 0 | 0 | $0 |
| Walter Noot | CHIEF OPERATING OFFICER | 19 lutego 2026 A | 0 | 0 | 0 | $0 |
| Roy Truett | Chief Operating Officer | 27 lipca 2012 M | 0 | 0 | 0 | $0 |
| Kathryn Michelle Armstrong | CHIEF SCIENTIFIC OFFICER | 25 lipca 2026 M | 3 471 | 0 | 0 | $0 |
| Peter Benedict | CHIEF INFORMATION OFFICER | 25 lipca 2026 M | 422 | 0 | 0 | $0 |
| Brent Neidig | CHIEF COMMERCIAL OFFICER | 16 czerwca 2026 S | 0 | 0 | 3 | $-147 749 |
| Paul A. Jones | CHIEF PEOPLE OFFICER | 8 czerwca 2026 S | 0 | 0 | 1 | $-102 878 |
| David Mulham Mulham | CHIEF SALES OFFICER | 30 lipca 2025 S | 9 260 | 0 | 0 | $0 |
| Joshua Foukas | CHIEF LEGAL OFFICER | 12 marca 2025 S | 0 | 0 | 0 | $0 |
| Daniel A. Macuga | CHIEF COMMUNICATIONS OFFICER | 2 maja 2024 S | 0 | 0 | 0 | $0 |
| Robert A Sinnott | CHIEF SCIENTIFIC OFFICER | 5 marca 2024 S | 0 | 0 | 0 | $0 |
| James Bramble | Chief Legal Officer and Sec | 5 lutego 2018 A | 2 076 | 0 | 0 | $0 |
| Dave Wentz | Co-C.E.O. | 16 sierpnia 2016 M | 384 883 | 0 | 0 | $0 |
| Rick Stambaugh | Chief Information Officer | 17 grudnia 2015 M | 0 | 0 | 0 | $0 |
| Mark H Wilson | E.V.P. of Sales | 28 października 2010 M | 5 000 | 0 | 0 | $0 |
| Bradford Richardson | E.V.P. of Asia Pacific | 25 lutego 2008 S | 0 | 0 | 0 | $0 |
| Xia Ding | Dyrektor | 23 lipca 2026 M | 8 278 | 0 | 0 | $0 |
| John Turman Fleming | Dyrektor | 23 lipca 2026 M | 5 862 | 0 | 1 | $-43 928 |
| Peggie Pelosi | Dyrektor | 23 lipca 2026 M | 6 061 | 0 | 0 | $0 |
| Scott J Nixon | Dyrektor | 23 lipca 2026 M | 11 445 | 0 | 0 | $0 |
| Frederic J Winssinger | Dyrektor | 23 lipca 2026 M | 9 733 | 0 | 0 | $0 |
| Timothy E Wood | Dyrektor | 23 lipca 2026 M | 11 837 | 0 | 0 | $0 |
| Gilbert A Fuller | Dyrektor | 23 lipca 2026 M | 1 632 | 0 | 3 | $-60 414 |
| Robert Auciaux | Dyrektor | 9 lutego 2022 M | 436 | 0 | 0 | $0 |
| Feng Peng | Dyrektor | 28 kwietnia 2021 M | 755 | 0 | 0 | $0 |
| Myron W. Wentz | Dyrektor | 4 lutego 2019 S | 9 865 614 | 0 | 0 | $0 |
| Jerry G Mcclain | Dyrektor | 4 marca 2016 M | 0 | 0 | 0 | $0 |
| Ronald S Poelman | Dyrektor | 8 lutego 2016 A | 0 | 0 | 0 | $0 |
| Denis E Waitley | Dyrektor | 3 listopada 2006 M | 0 | 0 | 0 | $0 |
| Gull Global Limited | Posiadacz 10% | 4 lutego 2019 S | 9 865 614 | 0 | 0 | $0 |
| GULL HOLDINGS LTD | Posiadacz 10% | 1 kwietnia 2015 J | 6 491 110 | 0 | 0 | $0 |
| Kevin Guest | — | 27 lutego 2026 M | 45 381 | 0 | 0 | $0 |
| Donald R. Williams | — | 1 maja 2017 A | — | 0 | 0 | $0 |
| Doug Braun | — | 16 grudnia 2015 M | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 3 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Gull Global Limited, Myron W. Wentz ×11 zgłoszenia | 30 marca 2026 | 40,10% | Aneks | — | SEC |
| Gull Holdings, Ltd., Myron W. Wentz, David A. Wentz, Jacquelyn R. Wentz, Bryan Wentz, Annette Wentz, Paul & Jane Meyer Family Foundation, Paul James Meyer, Alice Jane Meyer, Centre Island Properties, Ltd., Waco Boys Club Foundation, Inc., L-K Marketing Group, LLC, Beagle Irrevocable Asset Trust | 23 maja 2008 | — | Pierwotne zgłoszenie | — | SEC |
| Paul & Jane Meyer Family Foundation | 20 maja 2008 | — | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 38 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| DEEP · ETF Series Solutions | 0,95% | 13 646 NS | 31 maja 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,25% | 13 206 NS | 31 maja 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,11% | 45 046 SH | 8 sierpnia 2026 | Dziennie |
| EBIT · Harbor ETF Trust | 0,06% | 387 NS | 30 kwietnia 2026 | N-PORT |
| IWC · iShares Trust | 0,04% | 38 121 SH | 8 sierpnia 2026 | Dziennie |
| FNDA · SCHWAB STRATEGIC TRUST | 0,03% | 169 505 NS | 31 maja 2026 | N-PORT |
| VDC · VANGUARD WORLD FUND | 0,03% | 128 565 SH | 8 sierpnia 2026 | Dziennie |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 15 259 NS | 31 maja 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,02% | 87 994 NS | 30 kwietnia 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 9 639 SH | 8 sierpnia 2026 | Dziennie |
| DFAT · Dimensional ETF Trust | 0,01% | 97 080 NS | 30 kwietnia 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 24 189 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 18 642 NS | 31 maja 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,01% | 159 569 NS | 31 maja 2026 | N-PORT |
| IWN · iShares Trust | 0,01% | 101 080 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 64 278 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,01% | 60 807 NS | 30 kwietnia 2026 | N-PORT |
| SMLF · iShares Trust | 0,01% | 22 748 SH | 8 sierpnia 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1 195 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 4 685 NS | 30 kwietnia 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 283 211 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,01% | 508 NS | 31 maja 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 51 773 NS | 31 maja 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,00% | 2 158 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 397 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 406 NS | 31 maja 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 247 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 388 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 10 NS | 31 maja 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 5 468 NS | 31 maja 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 19 278 NS | 30 kwietnia 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 22 758 SH | 8 sierpnia 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 3 680 SH | 8 sierpnia 2026 | Dziennie |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 6 500 NS | 31 maja 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 1 784 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 124 681 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 350 035 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 790 SH | 8 sierpnia 2026 | Dziennie |